Meredith Ian T
- SEC CIK
- 0001693920
No open-market purchases or sales filed in the past year.
Current role at each company
- BSX Boston Scientific CorpEVP Global Chief Med Officeras of Mar 29, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Meredith Ian T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2021 (view filing) | Dec 28 | 1 day | Meredith Ian TEVP Global Chief Med Officer | SSale | −7.02K | $43.21 | −$303.2K | −21.1%26.2K after | |
| Mar 29, 2022 (view filing) | Mar 28 | 1 day | Meredith Ian TEVP Global Chief Med Officer | SSale | −6.59K | $43.68 | −$287.8K | −19.0%28.1K after |